Emerging paradigms in molecular imaging of neuroendocrine tumors: From dual-tracer PET to somatostatin receptor antagonists
Diagnostic and Interventional Imaging · 2025-11 · 106 (11) · 373-374
DOI: 10.1016/j.diii.2025.07.006 ↗Kurz gefasst
Editorial in der Zeitschrift Diagnostic and Interventional Imaging, 2025-11. Verfasst von Anna Pellat und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Endoscopy and Digestive Oncology Unit, Hopital Cochin, AP-HP, 75014 Paris, France; Université Paris Cité, UFR de médecine, Faculté …. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology, Endoscopy and Digestive Oncology Unit, Hopital Cochin, AP-HP, 75014 Paris, France; Université Paris Cité, UFR de médecine, Faculté de santé, 75006 Paris, France. Electronic address: anna.pellat@aphp.fr.
- Université Paris Cité, UFR de médecine, Faculté de santé, 75006 Paris, France; Department of Nuclear Medicine, Hopital Cochin, AP-HP, 75014 Paris, France.
Zitieren
APA
Pellat, A., & Cottereau, A. S. (2025). Emerging paradigms in molecular imaging of neuroendocrine tumors: From dual-tracer PET to somatostatin receptor antagonists. Diagnostic and Interventional Imaging, 106(11), 373-374. https://doi.org/10.1016/j.diii.2025.07.006
Vancouver
Pellat A, Cottereau AS. Emerging paradigms in molecular imaging of neuroendocrine tumors: From dual-tracer PET to somatostatin receptor antagonists. Diagnostic and Interventional Imaging. 2025;106(11):373-374. doi:10.1016/j.diii.2025.07.006
BibTeX
@article{Pellat2025,
author = {Pellat, Anna and Cottereau, Anne Ségolène},
title = {Emerging paradigms in molecular imaging of neuroendocrine tumors: From dual-tracer PET to somatostatin receptor antagonists},
journal = {Diagnostic and Interventional Imaging},
year = {2025},
volume = {106},
number = {11},
pages = {373--374},
doi = {10.1016/j.diii.2025.07.006}
}
EUVIMED